Month: <span>September 2022</span>

Home / 2022 / September
Severe COVID-19 may be caused by ‘senile’ interferon response in older patients
Post

Severe COVID-19 may be caused by ‘senile’ interferon response in older patients

by Rockefeller University Press Transmission electron micrograph of SARS-CoV-2 virus particles (colored yellow) within the endosomes of a heavily infected nasal olfactory epithelial cell. Credit: NIAID Researchers in Germany have discovered that age-dependent impairments in antiviral interferon proteins underlie the increased susceptibility of older patients to severe COVID-19. The study, published today in the Journal of...

Researchers turn cancer cells into less harmful cell types
Post

Researchers turn cancer cells into less harmful cell types

by University of Basel High-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the high-throughput drug screen to identify inhibitors that induce ERα signaling in TNBC. Cells without active ERα signaling do not express GFP, whereas cells with active ERα signaling...

In-home wireless device tracks disease progression in Parkinson’s patients
Post

In-home wireless device tracks disease progression in Parkinson’s patients

by Adam Zewe, Massachusetts Institute of Technology The sensor operates like a low-power radar, where it captures radio waves to assess patients’ walking patterns, their disease progression, and the effects of medications. Credit: Liu et al., Sci. Transl. Med. 14, eadc9669 (2022) Parkinson’s disease is the fastest-growing neurodegenerative disease, now affecting more than 10 million people...

Link found between pain sensitivity and circadian rhythm
Post

Link found between pain sensitivity and circadian rhythm

by Bob Yirka, Medical Xpress The circadian rhythm and melatonin production of a human. Credit: Srruhh, CC BY-SA 4.0 , via Wikimedia Commons A team of researchers with members from Université Claude Bernard Lyon, Hospices Civils de Lyon and Paris-Saclay Université has found a link between pain sensitivity and a person’s circadian rhythm. In their paper...

Post

How the brain develops: a new way to shed light on cognition

A new study introduces a new neurocomputational model of the human brain that could shed light on how the brain develops complex cognitive abilities and advance neural artificial intelligence research. The study was carried out by an international group of researchers from the Institut Pasteur and Sorbonne Université in Paris, the CHU Sainte-Justine, Mila –...

Diabetes: Free Foods
Post

Diabetes: Free Foods

BY AMY CAMPBELL, MS, RD, LDN, CDCES | SEPTEMBER 13, 2022 Eating with diabetes is often thought to be one of the hardest parts about having the condition. Not only do you need to pay attention to carbohydrates, portions, and timing, but it can seem like everything you eat affects your blood sugars. (And eating is just part...

Post

Benefits and drawbacks of Going out with a UK Girl

Pros and cons of dating uk girl The united kingdom is a tiny country but it really is one of the the majority of successful nations around the world in the world. It is because its rich history and advanced economy. However , it is also known for its unique style and traditions. You can...

Post

Modelling study estimates the number of people living with Type 1 Diabetes is set to double by 2040

THE LANCET Peer-reviewed/Modelling/People A new modelling study estimates 8.4 million individuals were living with Type 1 Diabetes (T1D) globally in 2021 with an additional 3.7 million ‘missing people’ who would be alive with T1D if their mortality matched general population rates. The model predicts between 13.5 – 17.4 million people will be living with T1D...

Post

Calibr reports promising results from first-in-human clinical trial of switchable CAR-T (CLBR001 + SWI019)

SCRIPPS RESEARCH INSTITUTE LA JOLLA, CA— Calibr, a division of Scripps Research focused on the “bench to bedside” development of transformative medicines, today announced encouraging preliminary data from the first nine subjects in a first-in-human Phase 1 clinical trial studying the first switchable CAR-T cell product (CLBR001 + SWI019) for patients with B cell malignancies. The...

Post

NIH-funded study shows sound sleep supports immune function

NIH/NATIONAL HEART, LUNG AND BLOOD INSTITUTE Adults who cut back on sleep for 6 weeks had increased markers of inflammation   Getting a consistent good night’s sleep supports normal production and programming of hematopoietic stem cells, a building block of the body’s innate immune system, according to a small National Institutes of Health-supported study in humans...